ClinicalTrials.gg
Sign In

Drug

JS212 clinical trials

studies test it
5
open now
5
in phase 3
0
first study started
2025

Keep track of what changes. Save the JS212 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

JS212 for Injection
3

Studies by the year they started

5 studies that test it; most in 2026 (4)

Studies that test JS212, by start year
YearStudies
20251
20264

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
4
No phase
1

What it is tested for

Each study’s main condition, where its own words name it.

Triple Negative Breast Neoplasms
1

Who runs them

Industry 0 · Other 5

Shanghai Junshi Bioscience Co., Ltd. (4) · Huan Zhou (1)

Often tested with

Tested in the same studies.

JS111 (1) · JS213 (1)

Studies

Open first, then newest update. How each study uses JS212 is read from its arms, and is right about nine times in ten.

Testing it · 5

Given in every arm · 4 — JS212 is usual care beside what is tested